BioLife 解决方案

最新新闻

• 评级变动
  Northland Securities Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $31
  \u5e02\u573a\u8d44\u8baf · 2025/11/8
• Benchmark Co. Downgrades BioLife Solutions(BLFS.US) to Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• 评级变动
  H.C. Wainwright Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $32
  \u5e02\u573a\u8d44\u8baf · 2026/6/1
• Stephens Downgrades BioLife Solutions(BLFS.US) to Hold Rating, Raises Target Price to $31
  \u5e02\u573a\u8d44\u8baf · 2026/7/27
• 评级变动
  Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/6/25
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX), Biohaven Ltd. (BHVN) and BioLife Solutions (BLFS)
  TipRanks · 2026/6/25
• 评级变动
  Analysts' Top Healthcare Picks: Alto Neuroscience, Inc. (ANRO), BioLife Solutions (BLFS)
  TipRanks · 2026/5/14
• 评级变动
  TD Cowen Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $33
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• 评级变动
  Maxim Group Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $34
  \u5e02\u573a\u8d44\u8baf · 2026/5/14
• 评级变动
  Northland Securities Maintains BioLife Solutions(BLFS.US) With Buy Rating, Raises Target Price to $34
  \u5e02\u573a\u8d44\u8baf · 2026/1/5
• 评级变动
  Northland Securities Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $34
  \u5e02\u573a\u8d44\u8baf · 2026/3/24
• 评级变动
  Lake Street Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $33
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• Maxim Group Maintains BioLife Solutions(BLFS.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/7/24
• Earnings Flash (BLFS) BioLife Solutions, Inc. Reports Q2 Revenue $28.5M, Vs. FactSet Est of $27.8M
  MT Newswires · 2026/8/7
• 评级变动
  Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Buy Rating, Announces Target Price $32
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• 公司公告
  BioLife Solutions: BioLife Solutions, Inc. - Anticipated Adjustment Option Symbol: BLFS New Symbol: RGEN1
  OCC · 2026/9/10
• Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• 评级变动
  A Quick Look at Today's Ratings for BioLife Solutions(BLFS.US), With a Forecast Between $31 to $31
  \u5e02\u573a\u8d44\u8baf · 2026/7/23
• 评级变动
  Lake Street Maintains BioLife Solutions(BLFS.US) With Buy Rating, Raises Target Price to $33
  \u5e02\u573a\u8d44\u8baf · 2025/11/8

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。